2018
DOI: 10.25077/jka.v7i1.775
|View full text |Cite
|
Sign up to set email alerts
|

Ekspresi Gen Tissue Inhibitor Metalloproteinase-1 Pada Sel Sinoviosit Osteoartritis Grade IV Setelah Pemberian Diacerein

Abstract: Disease Modifying Osteoarthritis Drugs (DMOADs) merupakan agen yang dapat mencegah, menghambat perkembangan atau mengembalikan perubahan morfologi pada penderita osteoarthritis. Salah satu yang termasuk DMOADs ini adalah diacerein. Diacerein menstimulasi terbentuknya Tissue Inhibitor Metalloproteinase-1 (TIMP-1) pada percobaan hewan. Tujuan penelitian ini adalah mengetahui pengaruh penggunaan diacerein pada ekspresi genTIMP-1 pada sel primer jaringan sinovial pasien osteoartritis. Pada penelitian ini dilakukan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Diacerein is one of the drugs, included in the disease-modifying osteoarthritis drug group (DMOADs), which aims to suppress the development of the disease rate, improving the structure and function of the cartilage and surrounding tissue (Sofia et al, 2018). Diacerein has a rhein structure, which is a molecule with anthraquinonic ring.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Diacerein is one of the drugs, included in the disease-modifying osteoarthritis drug group (DMOADs), which aims to suppress the development of the disease rate, improving the structure and function of the cartilage and surrounding tissue (Sofia et al, 2018). Diacerein has a rhein structure, which is a molecule with anthraquinonic ring.…”
Section: Introductionmentioning
confidence: 99%
“…Diacerein has been shown to be able to suppress the activity of catalytic protein MMPs, on the contrary, increase the expression and function of TIMPs in primary cells of osteoarthritis patients (Sofia et al, 2018). This effect is thought to occur through an inhibitory mechanism of IL-1 function and expression.…”
Section: Introductionmentioning
confidence: 99%